glp-1 therapy for diabetes Agonists Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1 receptor agonists and acute

The evidence is there

Drug classes to be on the lookout for are outlined in Table 2 , and include several major buckets: Incretins Plus : these assets often add additional agonism to the classic GLP-1 or GLP-1/GIP drugs

References Collins, L

Glycemic Safety Of particular importance given the glucagon receptor agonism component of retatrutide, there were no clinically significant increases in blood glucose or concerning hyperglycemic events despite glucagon's classical glucose-raising effects - confirming that the GLP-1 component successfully counteracts glucagon's impact on glucose homeostasis

This advantage continued over time, with engaged members seeing 29.1% greater average weight loss at 12 months

Im a believer